Track topics on Twitter Track topics that are important to you
Pharmacogenomics is the science of individualizing the drug, by studying of inherited variations in human genes that affect an individual's reaction to a particular drug. Pharmacogenomics also determine an individual's vulnerability to certain diseases. Globally, development of efficient and advance technology, rising demand for personalized drugs, growing incidences of several infectious and noninfectious diseases, rise in the awareness among people regarding pharmacogenomics, and increasing government initiative across the globe, are the prime growth drivers of global pharmacogenomics market. In addition, increase in adoption of pharmacogenomics in emerging economies such as China, India and others, will create new opportunities for global pharmacogenomics market. However, higher cost of the research and development, complex government approval process, and finding the association between a genetic marker and a phenotypic drug response are the key restraints for global pharmacogenomics market.
Geographically North America dominated global pharmacogenomics market because of rising demand of personalized medicines, high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and number of RD centres in developing nations such as China, and India in this region. Among all the applications, drug discovery has the highest market share in global pharmacogenomics market.
This report identifies the global pharmacogenomics market size in for the year 20142016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global pharmacogenomics market.
This report segments global pharmacogenomics market on the basis of method, therapeutic application, application, and regional market as follows:
Pharmacogenomics Market, By Method: Haplotype Analysis, and Multivariate Techniques
Pharmacogenomics Market, By Therapeutic Application: Cancer, Oncology, and Cardiovascular
The report has focused study on pharmacogenomics market by basis of application such as: Drug Safety, Tailor Treatments, and Drug Discovery
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, AsiaPacific APAC, and Rest of the World RoW covering all the major country level markets in each of the region
This report identifies all the major companies operating in the pharmacogenomics market. Some of the major companies' profiles in detail are as follows:
BristolMyers Squibb Company
F. HoffmannLa Roche Ltd.
Merck Co., Inc.
Abbott Laboratories, Inc.
Original Article: Pharmacogenomics Market: By Method Haplotype Analysis, Multivariate Techniques, By Therapeutic Application Cancer, Oncology, Cardiovascular, By Application Drug Safety, Tailor Treatments, Drug Discovery By RegionForecast 20162021 [Updated: 02032016] PricNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...